Overview

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.
Phase:
Phase 3
Details
Lead Sponsor:
Upsher-Smith Laboratories
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate